Wai Chun Bio-Technology Limited (Wai Chun Biotec) has suspended trading in its shares on the Stock Exchange of Hong Kong from 9:00 a.m. on Monday, 13 April 2026. The halt is scheduled for one trading day and was requested to facilitate the release of an announcement containing inside information about the company.
According to the filing, the board currently comprises one executive director—Chairman and Chief Executive Officer Mr. Lam Ka Chun—and three independent non-executive directors: Mr. Wong Po Keung, Mr. Wang Ziniu and Ms. Xu Huiling.
The company stated that further details will be provided in the forthcoming announcement. Investors are advised to monitor subsequent disclosures from Wai Chun Biotec for additional information regarding the inside information referenced.